カテゴリ： FactMR, 世界, 医療/バイオ

小児神経芽腫治療のグローバル市場2023～2033：免疫療法、化学療法、その他

■ 英語タイトル：Pediatric Neuroblastoma Treatment Market By Therapy Type (Immunotherapy, Chemotherapy & Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores) & By Region - Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23MA122）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23MA122
■ 発行日：2023年3月21日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[小児神経芽腫治療のグローバル市場2023～2033：免疫療法、化学療法、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社による最新調査レポートは、世界の小児神経芽腫治療市場について2023年度から2033年度までの10年間にわたる市場規模予測を掲載しています。本レポートは、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場展望、治療種類別（免疫療法、化学療法、その他）分析、流通チャネル別（病院薬局、小売薬局、ドラッグストア）分析、地域別（北米、ヨーロッパ、その他地域）分析などの項目を掲載しています。また、企業情報として、United Therapeutics Corporation、APEIRON Biologics AG、Baxterなどが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場展望
・世界の小児神経芽腫治療市場規模：治療種類別
- 免疫療法の市場規模
- 化学療法の市場規模
- その他治療種類の市場規模
・世界の小児神経芽腫治療市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- ドラッグストアチャネルの市場規模
・世界の小児神経芽腫治療市場規模：地域別
- 北米の小児神経芽腫治療市場規模
- ヨーロッパの小児神経芽腫治療市場規模
- その他地域の小児神経芽腫治療市場規模
・企業情報

本レポートには、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。なお、購読者に実用的な洞察を提供し、熟考して市場の状況を示し、小児神経芽腫治療における競争レベルを推測するのに役立ちます。

Pediatric Neuroblastoma Treatment Market – Scope of Report

A recent study by Fact.MR on the pediatric neuroblastoma treatment market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering pediatric neuroblastoma treatment.

The study also provides the dynamics responsible for influencing the future status of the pediatric neuroblastoma treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the pediatric neuroblastoma treatment market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of pediatric neuroblastoma treatment across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of pediatric neuroblastoma treatment during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for pediatric neuroblastoma treatment are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global pediatric neuroblastoma treatment market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the pediatric neuroblastoma treatment market during the forecast period.

Country-specific valuation on demand for pediatric neuroblastoma treatment has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of pediatric neuroblastoma treatment, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering pediatric neuroblastoma treatment has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the pediatric neuroblastoma treatment domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Market Analysis and Forecast, 2023–2033

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Epidemiology Pediatric Neuroblastoma

    5.2. Pipeline Analysis

    5.3. Key Unmet Needs in the Market

    5.4. Global Market: Rate of Metastasis in Neuroblastoma

    5.5. Global Market: Neuroblastoma Relapse/Refractory cases

    5.6. Rate of Utilization of MIBG-131

6. Global Market Analysis and Forecast, by Therapy Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Therapy Type, 2023–2033

        6.3.1. Immunotherapy

        6.3.2. Chemotherapy

        6.3.3. Others

    6.4. Market Attractiveness, by Therapy Type

7. Global Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Distribution Channel, 2023–2033

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies & Drug Stores

    7.4. Market Attractiveness, by Distribution Channel

8. Global Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Rest of the World

    8.3. Market Attractiveness, by Region

9. North America Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Therapy Type, 2023–2033

        9.2.1. Immunotherapy

        9.2.2. Chemotherapy

        9.2.3. Others

    9.3. Market Value Forecast, by Distribution Channel, 2023–2033

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies & Drug Stores

    9.4. Market Value Forecast, by Country, 2023–2033

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Therapy Type

        9.5.2. By Distribution Channel

        9.5.3. By Country

10. Europe Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Therapy Type, 2023–2033

        10.2.1. Immunotherapy

        10.2.2. Chemotherapy

        10.2.3. Others

    10.3. Market Value Forecast, by Distribution Channel, 2023–2033

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies & Drug Stores

    10.4. Market Value Forecast, by Country/Sub-region, 2023–2033

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Therapy Type

        10.5.2. By Distribution Channel

        10.5.3. By Country/Sub-region

11. Rest of the World Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Therapy Type, 2023–2033

        11.2.1. Immunotherapy

        11.2.2. Chemotherapy

        11.2.3. Others

    11.3. Market Value Forecast, by Distribution Channel, 2023–2033

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies & Drug Stores

    11.4. Market Attractiveness Analysis

        11.4.1. By Therapy Type

        11.4.2. By Distribution Channel

12. Company Profiles

    12.1. United Therapeutics Corporation

        12.1.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.1.2. Product Portfolio

        12.1.3. SWOT Analysis

        12.1.4. Financial Overview

        12.1.5. Strategic Overview

    12.2. APEIRON Biologics AG

        12.2.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.2.2. Product Portfolio

        12.2.3. SWOT Analysis

        12.2.4. Financial Overview

        12.2.5. Strategic Overview

    12.3. Baxter

        12.3.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.3.2. Product Portfolio

        12.3.3. SWOT Analysis

        12.3.4. Financial Overview

        12.3.5. Strategic Overview

    12.4. Cellectar Biosciences, Inc.

        12.4.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.4.2. Product Portfolio

        12.4.3. SWOT Analysis

        12.4.4. Financial Overview

        12.4.5. Strategic Overview

    12.5. Pfizer, Inc.

        12.5.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.5.2. Product Portfolio

        12.5.3. SWOT Analysis

        12.5.4. Financial Overview

        12.5.5. Strategic Overview

    12.6. MacroGenics, Inc.

        12.6.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.6.2. Product Portfolio

        12.6.3. SWOT Analysis

        12.6.4. Financial Overview

        12.6.5. Strategic Overview

    12.7. Bayer AG

        12.7.1. Company Overview (HQ, Business Segments, Employee Strength)

        12.7.2. Product Portfolio

        12.7.3. SWOT Analysis

        12.7.4. Financial Overview

        12.7.5. Strategic Overview

Table 01: List of acronyms used in the report

Table 02: Global Market: Pipeline Analysis

Table 03: Global Market: Pipeline Analysis

Table 04: Global Market: Pipeline Analysis

Table 05: Global Market: Pipeline Analysis

Table 06: Global Market: Pipeline Analysis

Table 07: Global Market: Pipeline Analysis

Table 08: Global Market: Pipeline Analysis

Table 09: Global Market: Pipeline Analysis

Table 10: Global Market: Pipeline Analysis

Table 11: Global Market: Pipeline Analysis

Table 12: Global Market: Pipeline Analysis

Table 13: Global Market: Pipeline Analysis

Table 14: Global Market: Pipeline Analysis

Table 15: Global Market Value (US$ Mn) Forecast, by Therapy Type, 2023–2033

Table 16: Global Market Value (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 17: Global Market Value (US$ Mn) Forecast, by Region, 2023–2033

Table 18: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 19: North America Market Value (US$ Mn) Forecast, by Therapy Type, 2023–2033

Table 20: North America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 21: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 22: Europe Market Value (US$ Mn) Forecast, by Therapy Type, 2023–2033

Table 23: Europe Market Value (US$ Mn) Forecast, by Distribution Channel, 2023–2033

Table 24: Rest of the World Market Value (US$ Mn) Forecast, by Therapy Type, 2023–2033

Table 25: Rest of the World Market Value (US$ Mn) Forecast, by Distribution Channel, 2023–2033

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 乳がん治療薬のグローバル市場（2023-2032）：化学療法、ホルモン療法、標的療法、免疫療法
  • 転移性がん治療薬のグローバル市場（2023-2032）：化学療法、ホルモン療法、標的療法、免疫療法
  • ペット用がん治療薬のグローバル市場：化学療法、放射線療法、免疫療法、併用療法、その他
  • 非ホジキンリンパ腫治療薬のグローバル市場（2022年-2029年）：免疫療法、化学療法、標的療法、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23MA122 )"小児神経芽腫治療のグローバル市場2023～2033：免疫療法、化学療法、その他" (英文：Pediatric Neuroblastoma Treatment Market By Therapy Type (Immunotherapy, Chemotherapy & Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores) & By Region - Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。